How the U.S. can keep biomedical innovation flowing

04/10/2014 | Hill, The

The U.S. is the world's most important biomedical research lab but isn't guaranteed to remain the top innovator, writes Celgene CEO Robert Hugin. "Government, academia, and private firms must collaborate to ensure the health of our nation's ecosystem of innovation -- and to secure the medical and fiscal rewards it offers. For the sake of patients -- and the broader economy -- America's leaders must help make that happen," Hugin contends.

View Full Article in:

Hill, The

Published in Brief: